Free Trial

Universal Beteiligungs und Servicegesellschaft mbH Takes $1.25 Million Position in Varex Imaging $VREX

Varex Imaging logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Universal Beteiligungs und Servicegesellschaft mbH acquired 107,080 shares of Varex Imaging (NASDAQ:VREX) in Q4, a position valued at about $1.247 million and representing 0.26% ownership.
  • Director Jay K. Kunkel sold 4,510 shares at an average price of $11.14 on March 20, cutting his holding by 16.13%; insiders now own 4.60% of the company.
  • Varex posted quarterly EPS $0.19 (beat) and revenue $209.6M, set Q2 2026 guidance of $0.15–$0.25 EPS, and carries a MarketBeat consensus rating of "Moderate Buy" with a $16.17 price target.
  • MarketBeat previews top five stocks to own in June.

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Varex Imaging (NASDAQ:VREX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 107,080 shares of the company's stock, valued at approximately $1,247,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.26% of Varex Imaging at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in VREX. Empowered Funds LLC raised its stake in shares of Varex Imaging by 7.3% in the first quarter. Empowered Funds LLC now owns 179,128 shares of the company's stock valued at $2,078,000 after acquiring an additional 12,151 shares during the period. Jane Street Group LLC raised its stake in shares of Varex Imaging by 17.9% in the first quarter. Jane Street Group LLC now owns 159,362 shares of the company's stock valued at $1,849,000 after acquiring an additional 24,160 shares during the period. Rhumbline Advisers raised its stake in shares of Varex Imaging by 4.6% in the second quarter. Rhumbline Advisers now owns 61,820 shares of the company's stock valued at $536,000 after acquiring an additional 2,694 shares during the period. Hsbc Holdings PLC raised its stake in shares of Varex Imaging by 19.7% in the second quarter. Hsbc Holdings PLC now owns 47,525 shares of the company's stock valued at $408,000 after acquiring an additional 7,825 shares during the period. Finally, Quantbot Technologies LP raised its stake in shares of Varex Imaging by 25.1% in the second quarter. Quantbot Technologies LP now owns 47,292 shares of the company's stock valued at $410,000 after acquiring an additional 9,476 shares during the period.

Insider Transactions at Varex Imaging

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of the stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the transaction, the director directly owned 23,450 shares in the company, valued at $261,233. This represents a 16.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is currently owned by insiders.

Varex Imaging Trading Down 0.3%

VREX stock opened at $11.61 on Friday. The company has a market capitalization of $486.46 million, a PE ratio of -7.08 and a beta of 0.96. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $14.56. The firm's 50-day moving average is $11.64 and its 200 day moving average is $12.16. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.89 and a quick ratio of 1.87.

Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.14 by $0.05. The company had revenue of $209.60 million for the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, research analysts anticipate that Varex Imaging will post 0.93 EPS for the current year.

Wall Street Analyst Weigh In

VREX has been the topic of several recent analyst reports. Wall Street Zen downgraded shares of Varex Imaging from a "strong-buy" rating to a "buy" rating in a research note on Saturday, April 25th. B. Riley Financial reissued a "buy" rating on shares of Varex Imaging in a research note on Thursday, February 12th. Weiss Ratings reissued a "sell (d-)" rating on shares of Varex Imaging in a research note on Friday, March 27th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $14.50 price target on shares of Varex Imaging in a research note on Monday, February 2nd. Finally, Zacks Research raised shares of Varex Imaging from a "hold" rating to a "strong-buy" rating in a research note on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $16.17.

Get Our Latest Stock Report on Varex Imaging

Varex Imaging Company Profile

(Free Report)

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

Featured Articles

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX - Free Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Varex Imaging Right Now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines